metformin plus phentermine For weight loss specifically, some providers combine metformin with phentermine as a lower-cost alternative
Retatrutide adds a third receptor pathway (glucagon) on top of the GLP-1 and GIP pathways targeted by tirzepatide, and the GLP-1 pathway targeted by semaglutide but unlike both of those, retatrutide remains investigational and not FDA-approved
In trials, retatrutide has produced greater average weight loss than Mounjaro, but it isnt approved or available yet, so it cant be prescribed in the UK
Call if youre looking to find a provider to assist you with your health and wellness
Sanyal 2024 confirmed this directly: -hydroxybutyrate (the biomarker for hepatic fatty-acid oxidation) rose +93% at 4 mg and +181% at 12 mg the signature of active glucagon-driven lipid mobilization, not a downstream consequence of weight loss
The reality is that 18% of Americans have taken a GLP-1 drug for one reason or another, and those numbers are expected to grow substantially this year as new pills hit the market and as prices come down